InvestorsHub Logo
Followers 22
Posts 747
Boards Moderated 0
Alias Born 09/07/2016

Re: rfj1862 post# 181821

Tuesday, 03/19/2019 10:53:33 AM

Tuesday, March 19, 2019 10:53:33 AM

Post# of 426367
RFJ - I think the importance of the AA/EPA ratio is not so much that it's a surrogate marker but the possibility that it could be THE marker that triages patients to a risk category that determines treatment.

For example, a patient may have CVD on a statin but has a great ratio - it may be that they do not benefit from Vascepa. Or vice versa they are lower risk primary prevention with a terrible ratio and they have a great RRR with V use.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News